Skip to content
Most recent
2023 Research Grant recipient
Spatial transcriptomics in diabetic macular ischaemia
2023 Research Grants Program
MDFA is Australia’s largest source of research funding in the field of macular disease outside of government
Excellence in Research Award in honour of Richard Grills (AM)
Composition and functionality of high-density lipoprotein in age-related macular degeneration and a high-risk disease phenotype
2023 Research Grant Family Fund recipient
Redefining macular disease diagnosis to improve access to emerging therapies
2023 Research Grant Recipient
Investigating mitochondrial dysfunction in macular degeneration – towards new treatments and biomarkers
2023 Research Grant Family Fund recipient
Evaluating the potential of hyperspectral imaging for detecting and monitoring geographic atrophy Accurate monitoring of
Vabysmo® (faricimab) now available in Australia
Vabysmo is a new treatment for age-related macular degeneration and diabetic macular oedema and is now available on the Pharmaceutical Benefits Scheme (PBS) in Australia
2022 Research Update: Innovation continues in macular disease treatment
MDFA 2022 research update
MDFA involves macular disease community members in the research review process
MDFA is committing to macular disease research